市場調查報告書

G8各國的醫藥品產業指南 (2015年∼2024年)

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2015-2024

出版商 MarketLine 商品編碼 950908
出版日期 內容資訊 英文 225 Pages
訂單完成後即時交付
價格
G8各國的醫藥品產業指南 (2015年∼2024年) Pharmaceuticals Global Group of Eight (G8) Industry Guide 2015-2024
出版日期: 2020年06月30日內容資訊: 英文 225 Pages
簡介

G8各國的醫藥品市場,從2015年到2019年以2.2%的年複合成長率(CAGR)成長,2019年達到6,453億美元的規模。G8各國,從2019年到2024年的預測期間預計以0.1%的年複合成長率成長,2024年達到6,494億美元。

本報告提供全球主要8個國家(G8:美國,加拿大,德國,法國,英國,義大利,俄羅斯,日本)的醫藥品市場相關分析,全球整體及各國的市場規模趨勢預測 (過去、今後5年份) ,及各領域詳細趨勢,市場競爭概況,主要企業的簡介,各國的宏觀經濟指標等調查 。

目錄

第1章 簡介

第2章 G8各國的醫藥品市場

  • 產業的展望

第3章 加拿大的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第4章 法國的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第5章 德國的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第6章 義大利的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第7章 日本的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第8章 俄羅斯的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第9章 英國的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第10章 美國的醫藥品市場

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場預測
  • 波特的五力分析
  • 宏觀經濟指標

第11章 企業簡介

  • Johnson & Johnson
  • Pfizer Inc.
  • Apotex Pharmachem Inc
  • Laboratoires Pierre Fabre SA
  • AstraZeneca AB
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • A Menarini Industrie Farmaceutiche Riunite Srl
  • Recordati S.p.A.
  • Chiesi Farmaceutici SpA
  • 第一三共
  • 武田藥品工業
  • Astellas Pharma Inc.
  • 田邊三菱製藥
  • Sanofi SA
  • Les Laboratoires Servier
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.

第12章 附錄

目錄
Product Code: MLIG200014-02

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the G8 pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

The G8 countries contributed $645.3 billion in 2019 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.2% between 2015 and 2019. The G8 countries are expected to reach a value of $649.4 billion in 2024, with a CAGR of 0.1% over the 2019-24 period.

Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $409.4 billion in 2019. This was followed by Japan and Germany, with a value of $59.3 and $40.2 billion, respectively.

The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $417.2 billion in 2016, followed by Japan and Germany with expected values of $53.6 and $39.6 billion, respectively.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players' G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
  • Reasons to Buy
  • What was the size of the G8 pharmaceuticals market by value in 2019?
  • What will be the size of the G8 pharmaceuticals market in 2024?
  • What factors are affecting the strength of competition in the G8 pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the G8 pharmaceuticals market?

Table of Contents

1 Introduction

  • 1.1. What is this report about?
  • 1.2. Who is the target reader?
  • 1.3. How to use this report
  • 1.4. Definitions

2 Group of Eight (G8) Pharmaceuticals

  • 2.1. Industry Outlook

3 Pharmaceuticals in Canada

  • 3.1. Market Overview
  • 3.2. Market Data
  • 3.3. Market Segmentation
  • 3.4. Market outlook
  • 3.5. Five forces analysis
  • 3.6. Macroeconomic Indicators

4 Pharmaceuticals in France

  • 4.1. Market Overview
  • 4.2. Market Data
  • 4.3. Market Segmentation
  • 4.4. Market outlook
  • 4.5. Five forces analysis
  • 4.6. Macroeconomic Indicators

5 Pharmaceuticals in Germany

  • 5.1. Market Overview
  • 5.2. Market Data
  • 5.3. Market Segmentation
  • 5.4. Market outlook
  • 5.5. Five forces analysis
  • 5.6. Macroeconomic Indicators

6 Pharmaceuticals in Italy

  • 6.1. Market Overview
  • 6.2. Market Data
  • 6.3. Market Segmentation
  • 6.4. Market outlook
  • 6.5. Five forces analysis
  • 6.6. Macroeconomic Indicators

7 Pharmaceuticals in Japan

  • 7.1. Market Overview
  • 7.2. Market Data
  • 7.3. Market Segmentation
  • 7.4. Market outlook
  • 7.5. Five forces analysis
  • 7.6. Macroeconomic Indicators

8 Pharmaceuticals in Russia

  • 8.1. Market Overview
  • 8.2. Market Data
  • 8.3. Market Segmentation
  • 8.4. Market outlook
  • 8.5. Five forces analysis
  • 8.6. Macroeconomic Indicators

9 Pharmaceuticals in The United Kingdom

  • 9.1. Market Overview
  • 9.2. Market Data
  • 9.3. Market Segmentation
  • 9.4. Market outlook
  • 9.5. Five forces analysis
  • 9.6. Macroeconomic Indicators

10 Pharmaceuticals in The United States

  • 10.1. Market Overview
  • 10.2. Market Data
  • 10.3. Market Segmentation
  • 10.4. Market outlook
  • 10.5. Five forces analysis
  • 10.6. Macroeconomic Indicators

11 Company Profiles

  • 11.1. Johnson & Johnson
  • 11.2. Pfizer Inc.
  • 11.3. Apotex Pharmachem Inc
  • 11.4. Laboratoires Pierre Fabre SA
  • 11.5. AstraZeneca AB
  • 11.6. Novartis AG
  • 11.7. F. Hoffmann-La Roche Ltd
  • 11.8. Bayer AG
  • 11.9. Boehringer Ingelheim GmbH
  • 11.10. A Menarini Industrie Farmaceutiche Riunite Srl
  • 11.11. Recordati S.p.A.
  • 11.12. Chiesi Farmaceutici SpA
  • 11.13. Daiichi Sankyo Co Ltd
  • 11.14. Takeda Pharmaceutical Company Limited
  • 11.15. Astellas Pharma Inc.
  • 11.16. Mitsubishi Tanabe Pharma Corporation
  • 11.17. Sanofi SA
  • 11.18. Les Laboratoires Servier
  • 11.19. GlaxoSmithKline Plc
  • 11.20. Merck & Co., Inc.

12 Appendix

  • 12.1. Methodology
  • 12.2. About MarketLine

List of Tables

  • Table 1: G8 pharmaceuticals industry, revenue($bn), 2015-24
  • Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2015-19
  • Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2019-24
  • Table 4: Canada pharmaceuticals market value: $ billion, 2015-19
  • Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 6: Canada pharmaceuticals market share: % share, by value, 2019
  • Table 7: Canada pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 8: Canada size of population (million), 2015-19
  • Table 9: Canada gdp (constant 2005 prices, $ billion), 2015-19
  • Table 10: Canada gdp (current prices, $ billion), 2015-19
  • Table 11: Canada inflation, 2015-19
  • Table 12: Canada consumer price index (absolute), 2015-19
  • Table 13: Canada exchange rate, 2015-19
  • Table 14: France pharmaceuticals market value: $ billion, 2015-19
  • Table 15: France pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 16: France pharmaceuticals market share: % share, by value, 2019
  • Table 17: France pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 18: France size of population (million), 2015-19
  • Table 19: France gdp (constant 2005 prices, $ billion), 2015-19
  • Table 20: France gdp (current prices, $ billion), 2015-19
  • Table 21: France inflation, 2015-19
  • Table 22: France consumer price index (absolute), 2015-19
  • Table 23: France exchange rate, 2015-19
  • Table 24: Germany pharmaceuticals market value: $ billion, 2015-19
  • Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 26: Germany pharmaceuticals market share: % share, by value, 2019
  • Table 27: Germany pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 28: Germany size of population (million), 2015-19
  • Table 29: Germany gdp (constant 2005 prices, $ billion), 2015-19
  • Table 30: Germany gdp (current prices, $ billion), 2015-19
  • Table 31: Germany inflation, 2015-19
  • Table 32: Germany consumer price index (absolute), 2015-19
  • Table 33: Germany exchange rate, 2015-19
  • Table 34: Italy pharmaceuticals market value: $ billion, 2015-19
  • Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 36: Italy pharmaceuticals market share: % share, by value, 2019
  • Table 37: Italy pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 38: Italy size of population (million), 2015-19
  • Table 39: Italy gdp (constant 2005 prices, $ billion), 2015-19
  • Table 40: Italy gdp (current prices, $ billion), 2015-19
  • Table 41: Italy inflation, 2015-19
  • Table 42: Italy consumer price index (absolute), 2015-19
  • Table 43: Italy exchange rate, 2015-19
  • Table 44: Japan pharmaceuticals market value: $ billion, 2015-19
  • Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 46: Japan pharmaceuticals market share: % share, by value, 2019
  • Table 47: Japan pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 48: Japan size of population (million), 2015-19
  • Table 49: Japan gdp (constant 2005 prices, $ billion), 2015-19
  • Table 50: Japan gdp (current prices, $ billion), 2015-19
  • Table 51: Japan inflation, 2015-19
  • Table 52: Japan consumer price index (absolute), 2015-19
  • Table 53: Japan exchange rate, 2015-19
  • Table 54: Russia pharmaceuticals market value: $ billion, 2015-19
  • Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2019
  • Table 56: Russia pharmaceuticals market share: % share, by value, 2019
  • Table 57: Russia pharmaceuticals market value forecast: $ billion, 2019-24
  • Table 58: Russia size of population (million), 2015-19
  • Table 59: Russia gdp (constant 2005 prices, $ billion), 2015-19

List of Figures

  • Figure 1: G8 pharmaceuticals industry, revenue($bn), 2015-24
  • Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2019
  • Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2015-19
  • Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2019-24
  • Figure 5: Canada pharmaceuticals market value: $ billion, 2015-19
  • Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 7: Canada pharmaceuticals market share: % share, by value, 2019
  • Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2019
  • Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2019
  • Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2019
  • Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2019
  • Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2019
  • Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2019
  • Figure 15: France pharmaceuticals market value: $ billion, 2015-19
  • Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 17: France pharmaceuticals market share: % share, by value, 2019
  • Figure 18: France pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 19: Forces driving competition in the pharmaceuticals market in France, 2019
  • Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2019
  • Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2019
  • Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2019
  • Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2019
  • Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2019
  • Figure 25: Germany pharmaceuticals market value: $ billion, 2015-19
  • Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 27: Germany pharmaceuticals market share: % share, by value, 2019
  • Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2019
  • Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2019
  • Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2019
  • Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2019
  • Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2019
  • Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2019
  • Figure 35: Italy pharmaceuticals market value: $ billion, 2015-19
  • Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 37: Italy pharmaceuticals market share: % share, by value, 2019
  • Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2019
  • Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2019
  • Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2019
  • Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2019
  • Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2019
  • Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2019
  • Figure 45: Japan pharmaceuticals market value: $ billion, 2015-19
  • Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 47: Japan pharmaceuticals market share: % share, by value, 2019
  • Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2019
  • Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2019
  • Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2019
  • Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2019
  • Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2019
  • Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2019
  • Figure 55: Russia pharmaceuticals market value: $ billion, 2015-19
  • Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2019
  • Figure 57: Russia pharmaceuticals market share: % share, by value, 2019
  • Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2019-24
  • Figure 59: Forces driving competition in the pharmaceuticals market in Russia, 2019
  • Figure 60: Drivers of buyer power in the pharmaceuticals market in Russia, 2019